$9.820
-0.050 (-0.51%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCRX por análisis de gráficos similares
Alphio's BCRX stock price prediction model matches the current BioCryst Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.73 (-0.96%). The 1-week path is $9.70 (-1.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals appears to be a good buy right now due to its strong revenue growth and profitability outlook. The company expects Orladeyo sales to reach between $625 million and $645 million for 2023, contributing to a total revenue of over $2 billion since its U.S. approval. Additionally, the stock has shown a year-to-date increase of 30.93%, reflecting positive market sentiment. However, a risk to consider is the negative net income reported for Q1 2026, which was -721.81 million USD, highlighting potential volatility in earnings.
BCRX cerró en $9.82 el Friday, tras bajar -0.51%
BioCryst Pharmaceuticals, Inc. (BCRX) last closed at $9.82, losing -0.51%. These facts feed the 1-day and 1-week BCRX price prediction above.
Factores de la previsión
Los factores de la previsión de BioCryst Pharmaceuticals, Inc. (BCRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCRX, ordenadas por similitud.
Análisis de estacionalidad de BCRX
Historically the probability of a positive August return for BCRX is 100.00%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $13.03 | $17.17 | $20.08 | +74.83% |
| Sep 2026 | $13.91 | $15.24 | $16.69 | +55.21% |
| Oct 2026 | $16.05 | $16.54 | $19.80 | +68.45% |
| Nov 2026 | $12.53 | $14.03 | $16.10 | +42.88% |
| Dec 2026 | $15.40 | $17.17 | $18.22 | +74.83% |
En 2026, se proyecta que BioCryst Pharmaceuticals, Inc. (BCRX) oscile entre $12.53 y $20.08.
Previsión mensual de BioCryst Pharmaceuticals, Inc. para 2026
En Aug de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $17.17, con un mínimo de $13.03 y un máximo de $20.08.
En Sep de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $15.24, con un mínimo de $13.91 y un máximo de $16.69.
En Oct de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $16.54, con un mínimo de $16.05 y un máximo de $19.80.
En Nov de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $14.03, con un mínimo de $12.53 y un máximo de $16.10.
En Dec de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $17.17, con un mínimo de $15.40 y un máximo de $18.22.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.